Skip to content

Clinical trials

Phase 3 Astrocytoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Astrocytoma Phase: Phase 3 Country / region: Germany Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20071
20081
20092
20161
20181
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status2
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Novartis Pharmaceuticals3
Heidelberg University1
Isarna Therapeutics GmbH1
Neuro-Oncology Working Group of the German Cancer Society1
Orbus Therapeutics, Inc.1
University of Göttingen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Astrocytoma13
Brain Neoplasms5
Glioblastoma5
Central Nervous System Neoplasms4
Glioma4
Oligodendroglioma3
Tuberous Sclerosis2
Adenocarcinoma1
Angiomyolipoma1
Diffuse Intrinsic Pontine Glioma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.